Results
1 -
7 of
7Centrally-administered AMPA antagonists increase locomotion in parkinsonian rats, Journal of Neural Transmission - Parkinson's Disease and Dementia Section Behavioral and Histochemical Studies in Repeated Cerebral Ischemia in Rats, Catecholamine Research YM90K, an AMPA receptor antagonist, protects against ischemic damage caused by permanent and transient middle cerebral artery occlusion in rats, Naunyn-Schmiedeberg's Archives of Pharmacology YM-900 well tolerated in phase I study, Inpharma Weekly